CRVS — Corvus Pharmaceuticals Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Corvus Pharmaceuticals Inc (CRVS), worth $19.22M combined. Over the quarter 2 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Emerald | $10.24M | 0.24% | -0.1% |
| Emerald Mutual | $7.86M | 0.28% | +14.6% |
| Persistent | $1.12M | 0.35% | +20.5% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.